Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Characterization of mir-9 overexpressing tumors and their treatment and specific markers

A marker and characterization technology, applied in the field of pharmacy, can solve problems such as unclear role of exosomes

Inactive Publication Date: 2021-05-18
SICHUAN UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there is evidence that exosomes regulate tumor development and metastasis, the role of exosomes in tumor angiogenesis (especially after AATs) is unclear

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Characterization of mir-9 overexpressing tumors and their treatment and specific markers
  • Characterization of mir-9 overexpressing tumors and their treatment and specific markers
  • Characterization of mir-9 overexpressing tumors and their treatment and specific markers

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0168] The present invention will be further illustrated by the following embodiments in conjunction with the accompanying drawings in order to provide a basis for better understanding of the present invention.

[0169] 1. Method

[0170] The serial numbers before the subheadings are for ease of reading and are for reference only and do not determine the order.

[0171] 1.1 Cell culture

[0172] HUVECs (Allcells, Shanghai, China) were cultured using HUVEC medium (HUVEC-004; Allcells). We use third to sixth generation HUVECs. The human HCC cell lines SMMC-7721 and Huh7 were purchased from the American Type Culture Collection (ATCC, Manassas, Virginia, USA) and cultured in Dulbecco's Modified Eagle's Nest with 10% fetal bovine serum (FBS; Hyclone). Growth was carried out in Hyclone medium high glucose medium (Hyclone; GE Healthcare, Logan, Utah, USA). Cells were maintained at 5% CO 2 , 37°C.

[0173] The MiR-9 mimic (5'-TCTTTGGTTATCTAGCTGTATGA-3') was inserted into the LV3...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
refractive indexaaaaaaaaaa
Login to View More

Abstract

The present invention provides a method for constructing tumors with high miR-9 expression, and found that vandetanib and 3-methyladenine can inhibit the tumor grafts constructed by this method, but lead to a large amount of VEGF-rich exosomes secretion. The present invention further provides corresponding treatment methods and therapeutic drugs or compositions of vandetanib and 3-methyladenine, a VEGF-rich exosome marker for evaluating the corresponding treatment process, and a method for characterizing the marker Reagent test kit. The present invention provides a new strategy for the treatment, prevention and therapeutic effect evaluation of tumors, especially tumors with high expression of miR-9.

Description

technical field [0001] The present invention relates to the field of pharmacy, relates to miR-9 high expression tumors and their treatment and characterization of specific markers, in particular to VEGF-rich exosomes in response to anti-angiogenesis and anti-autophagy therapy and their corresponding characterization and application. Background technique [0002] Anti-angiogenic therapies (AATs) aimed at treating tumors by inhibiting tumor angiogenesis and destroying existing tumor blood vessels have not achieved the desired effect 1,2 . The efficacy of AATs is short-lived, and after cessation of treatment, tumors relapse rapidly through different forms of angiogenesis, such as vessel selection, endothelial angiogenesis, and angiogenesis mimicry (VM). 3-7 . In addition, AATs can destroy the tumor vascular barrier, promote tumor cell invasion and metastasis, make cancer cells such as hepatocellular carcinoma (HCC) cells escape AATs, or form AATs resistance 6,7 . Metastasi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/867C12N5/10C12Q1/6886G01N33/569A61K31/517A61K31/52A61P35/00
CPCA61K31/517A61K31/52A61P35/00C12N15/86C12N2740/15043C12Q1/6886C12Q2600/178G01N33/56966A61K2300/00
Inventor 曾烨刘肖珩
Owner SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com